A multi-centre prospective controlled trial comparing calcineurin inhibitor monotherapy with sirolimus monthotherapy in hepatitis C infected patients with hepatic fibrosis following liver transplantatio

Phase 4

Completed

• Conditions: Topic: Oral and Gastrointestinal; Subtopic: Oral and Gastrointestinal (all Subtopics); Disease: Hepatology; Digestive System; Liver Transplantation

• Registration Number: ISRCTN26350966
• Lead Sponsor: Addenbrooke's Hospital (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-05-12
• Study Completion: 2013-12-01
• Last Update Posted: 11 February 2019

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

Not provided at time of registration

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
iver Biopsy Fibrosis Score

Secondary Outcome Measures

Name	Time	Method
<br> 1. Diabetic status<br> 2. Renal function<br> 3. Cardiovascular risk index<br>